Analyst Insights - Digital Health Posts
Read our Analysts’ insights and expert opinions on the latest healthcare technology industry developments and market trends. Signify Research provides both free insights and premium insights which are only available to subscribers of "Signify Premium Insights".
Click on the premium insights link below to filter for just the premium content.
VC Funding for AI in Drug Development & Clinical Trials Hits $5.2B
18th December 2019 – The market for AI in drug development and clinical trials is maturing and entering a new phase; total funding in the industry has reached $5.2B. Signify Research has analysed the investment landscape and categorised the industry into Information Synthesis, Drug Design and Clinical Trials.
Dedalus to Acquire Agfa’s HCIS Business: The Signify View
3rd December 2019 – Yesterday Agfa announced it had entered exclusive negotiations with Dedalus to sell part of its Healthcare IT business, here’s our take on the deal.
Trade Wars & Peace? The Radiography Market’s Reaction to Chinese-US Tariffs
21st November 2019 – The US-China trade war has been making headlines around the world since 2018 – but what effect have these tariffs had on the radiography market and how have vendors responded?
Integrated Care at Allscripts’ and InterSystems’ UK Summits
21st November 2019 – Allscripts and InterSytems recently held their UK analyst/customer events. For both integrated care in the UK was a key theme. Here’s our take on the key messages from both.
Ten factors radiologists should consider when selecting AI vendors
21st November 2019 – With over 150 independent software vendors developing machine learning solutions for medical imaging, sorting through the plethora of options to select vendors is a challenge. Here are 10 factors radiologists should consider.